A RANDOMIZED CROSSOVER TRIAL OF MEGESTROL-ACETATE VS TAMOXIFEN AS INITIAL TREATMENT FOR POST-MENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
STUART, N
TYRELL, C
SPOONER, D
KEEN, C
TAYLOR, A
TARRANT, J
BLACKLEDGE, G
WEBSTER, D
REES, G
机构：
[1] QUEEN ELIZABETH HOSP,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
[2] PLYMOUTH GEN HOSP,PLYMOUTH,DEVON,ENGLAND
[3] VELINDRE HOSP,CARDIFF,WALES
[4] STOKE MANDEVILLE HOSP,AYLESBURY,BUCKS,ENGLAND
[5] UNIV HOSP WALES,CARDIFF CF4 4XN,S GLAM,WALES
[6] ROYAL UNITED HOSP,BATH,AVON,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1987年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：859 / 860
页数：2
相关论文
共 50 条
  • [21] TAMOXIFEN VERSUS ETHINYL ESTRADIOL IN THE TREATMENT OF POST-MENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER
    BEEX, L
    PIETERS, G
    SMALS, A
    KOENDERS, A
    BENRAAD, T
    KLOPPENBORG, P
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 179 - 185
  • [22] MEGESTROL-ACETATE (M) VERSUS TAMOXIFEN (T) IN ADVANCED BREAST-CANCER - AN UPDATE
    MUSS, H
    PASCHOLD, E
    CASE, D
    SPURR, C
    JACKSON, D
    RICHARDS, F
    CRUZ, J
    ZEKAN, P
    WHITE, D
    COOPER, M
    STUART, J
    CHRISTIAN, R
    CAPIZZI, R
    MORGAN, T
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 183 - 183
  • [23] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER
    TCHEKMEDYIAN, NS
    TAIT, N
    AISNER, J
    SEMINARS IN ONCOLOGY, 1986, 13 (04) : 20 - 25
  • [24] ENDOCRINE EFFECTS OF THE COMBINATION OF MEGESTROL-ACETATE AND TAMOXIFEN IN THE TREATMENT OF METASTATIC BREAST-CANCER
    ALEXIEVAFIGUSCH, J
    BLANKENSTEIN, MA
    DEJONG, FH
    LAMBERTS, SWJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (09): : 1135 - 1140
  • [25] PROGESTIN THERAPY (MEGESTROL-ACETATE) IN ADVANCED BREAST-CANCER
    ALEXIEVAFIGUSCH, J
    VANGILSE, HA
    HOP, W
    PHOA, CH
    TEULINGS, FAG
    BLONKVANDERWIJST, J
    TREURNIET, RE
    CANCER TREATMENT REPORTS, 1979, 63 (07): : 1217 - 1217
  • [26] RANDOMIZED TRIAL OF LOW VS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN THE TREATMENT OF POST-MENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    CAVALLI, F
    GOLDHIRSCH, A
    JUNGI, G
    MARTZ, G
    MERMILLOD, B
    SCHAFER, P
    ALBERTO, P
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (03): : R11 - R11
  • [27] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    TCHEKMEDYIAN, NS
    TAIT, N
    ABRAMS, J
    AISNER, J
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 44 - 49
  • [28] RANDOMIZED TRIAL OF MEGESTROL-ACETATE VS MEGESTROL-ACETATE TAMOXIFEN FOR THE MANAGEMENT OF PROGRESSIVE OR RECURRENT EPITHELIAL OVARIAN-CARCINOMA
    BELINSON, JL
    MCCLURE, M
    BADGER, G
    GYNECOLOGIC ONCOLOGY, 1987, 28 (02) : 151 - 155
  • [29] CLINICAL AND ENDOCRINE EFFECTS OF MEGESTROL-ACETATE IN WOMEN WITH PRETREATED ADVANCED BREAST-CANCER
    VICARIO, G
    CELIO, L
    BAJETTA, E
    ZAMPINO, MG
    LONGHI, A
    BUZZONI, R
    BOTTI, C
    BOGNI, A
    BOMBARDIERI, E
    RIMASSA, L
    LAFFRANCHI, A
    ONCOLOGY REPORTS, 1995, 2 (01) : 63 - 68
  • [30] CYCLIC SEQUENTIAL ENDOCRINE THERAPY FOR ADVANCED BREAST-CANCER USING A COMBINATION OF TAMOXIFEN AND MEGESTROL-ACETATE
    CRAWFORD, DJ
    GEORGE, WD
    SMITH, DC
    STEWART, M
    PAUL, J
    LEAKE, RE
    ONCOLOGY, 1994, 51 : 13 - 18
12345